What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Estudio multicéntrico, aleatorizado, doble ciego, controlado conplacebo y de grupos paralelos para evaluar la eficacia y la seguridad del depemokimaben participantes adultos con EPOC e inflamación de tipo 2 Contact Protocol code: 222714 EudraCT code: No aplica Pathology: Malalties del sistema respiratori Principal investigator: Barrecheguren Fernández, Miriam Research group: Pneumologia Service: Pneumologia Phase: Fase III Recruiting: Closed Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 2, pivotal, multicéntrico y abierto de CC97540 (BMS 986353), células T con receptor de antígeno quimérico Nex T dirigidas a CD19, en participantes con lupus eritematoso sistémico activo (incluida la nefritis lúpica) con respuesta inadecuada a los glucocorticoides y al menos a 2 inmunosupresores (Breakfree-SLE) Contact Protocol code: CA061-1011 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Cortes Hernandez, Josefina Research group: Reumatologia Service: Reumatologia Phase: Fase II Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, randomizado, doble ciego, multicéntrico para evaluar la eficacia y seguridad de Riliprubart (SAR445088) en comparación con inmunoglobulina intravenosa (IVIg) en participantes con polineuropatía desmielinizante inflamatoria crónica (CIDP) Contact Protocol code: EFC18156 EudraCT code: No aplica Pathology: Malalties del sistema nerviós Principal investigator: Juntas Morales, Raul Research group: Sistema nerviós perifèric Service: Neurologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Ensayo doble ciego, aleatorizado y controlado con placebo paraevaluar la eficacia y la seguridad de nerandomilast durante 26 semanas en pacientescon enfermedades pulmonares intersticiales asociadas a enfermedades reumticasautoinmunitarias sist~micas (EPI-ERAS) Contact Protocol code: 1305-0046 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Guillen Del Castillo, Alfredo Research group: Malalties sistèmiques Service: Medicina Interna Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. An evaluation of bemnifosbuvir-ruzasvir (BEM/RZR) versus sofosbuvir-velpatasvir (SOF/VEL) for the treatment of chronic hepatitisC virus (HCV) infection in a phase 3 randomized, controlled, openlabel study. Contact Protocol code: AT-01B-008 EudraCT code: _ Pathology: Tumors Principal investigator: Buti Ferret, Maria Research group: Malalties hepàtiques Service: Hepatologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Título del estudio: Estudio de Fase 1/2, abierto, multicéntrico, para la determinación yexpansión de dosis para investigar la seguridad, tolerabilidad y eficacia de la terapiagénica ALXN2350 en participantes adultos con miocardiopatía dilatada relacionadacon la mutación BAG3Estudio de rendimiento de ARUP Laboratories: Prueba AAV9 TAb para la elegibilidad en elensayo clínico ALXN2350-DCM-201Estudio de rendimiento de AMBRY: Protocolo de estudio de rendimiento clínico para el usode la prueba BAG3Next para la inclusión de pacientes en un estudio de fase 1/2, abierto,multicéntrico que investiga la seguridad, tolerabilidad y eficacia de la terapia génica ALXN2350en participantes adultos con miocardiopatía dilatada relacionada con la mutación BAG3. Contact Protocol code: ALXN2350-DCM-201 EudraCT code: No aplica Pathology: Malalties del sistema circulatori Principal investigator: Limeres Freire, Javier Research group: Malalties cardiovasculars Service: Cardiologia Phase: Fase I Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase I, abierto y con un solo grupo para determinar laseguridad, la tolerabilidad y la eficacia preliminar de obe-cel en participantes conformas progresivas refractarias de esclerosis múltiple Contact Protocol code: AUTO1-MS1 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Montalban Gairín, Xavier Research group: Neuroimmunologia clínica Service: Neuroimmunologia Phase: Phase I Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. 2-Part Seamless Part A (Phase 2)/ Part B (Phase 3) Randomized, DoubleBlind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST) Contact Protocol code: 230LE301 EudraCT code: 2020-000727-40 Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Cortes Hernandez, Josefina Research group: Rheumatology Service: Rheumatology Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Professionals Daniela Alexia Leon Castillo Professionals Inés Faci Sánchez Professionals Sofia Chica Muñoz de Leon Professionals Iker Elosua Bayés Professionals Francisco José Aparicio Serrano Professionals Daniel Hernández Soria Professionals Maria Crespi Amer Professionals Alex Rovira Rincon Professionals Marta Castro D la Visitación Professionals Jesús Ruiz López Professionals Ariadna Masot LLima Professionals Chloé Pierret Pagination First page « Previous page ‹ … Page 304 Page 305 Current page 306 Page 307 Page 308 … Next page › Last page »
